Alzheimer's Disease

First Link® Dementia Helpline can provide you with the support and answeres you need.

Stand up against dementia stigma this Alzheimer’s Awareness Month

Jana Schulz of Cranbrook, B.C. – a registered social worker, working as…

  • Jan 9, 2023

 

January is Alzheimer’s Awareness Month. Photo: submitted

Alzheimer’s Awareness Month: help flip the script on dementia stigma

Campaign highlights people with dementia who continue to find moments of joy, peace and happiness

 

Interested in becoming a support group facilitator volunteer? Visit: alzbc.org/volunteer. Photo: Submitted

Alzheimer’s society seeks Kootenay-Boundary volunteers

As pandemic restrictions have eased, the Society has adopted a fully hybrid model.

Interested in becoming a support group facilitator volunteer? Visit: alzbc.org/volunteer. Photo: Submitted
A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)

Canada could see tripling of people living with dementia in next 30 years: Landmark study

The Alzheimer Society of Canada released a study that predicts triple the number of diagnoses

A new study estimates that 6.3 million Canadians will be diagnosed and living with dementia in the next 30 years (Photo: Alzheimer Society)
Richard and Mary. Photo: Submitted

‘Garden of Gratitude’ the centre of a new KBRH Health Foundation project

The Columbia View Lodge Garden of Gratitude grew from Mary and Richard’s story.

Richard and Mary. Photo: Submitted
In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)

U.S. approves much-debated Alzheimer’s drug aducanumab panned by experts

Drug from Biogen deemed “reasonably likely” to benefit Alzheimer’s patients

In this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administration approved aducanumab, the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease. (Biogen via AP)
Photo: Trail Times

Dementia helpline offered in West Kootenay

First Link provides dementia support and information weekdays until 8 p.m.

  • Oct 28, 2020
Photo: Trail Times
Free Alzheimer Society of BC webinars help local residents and caregivers living with dementia. (Alzheimer’s Society of B.C. photo)

Trail, Rossland residents learn to adapt dementia strategies

Alzheimer’s Society offers webinars to help cope with dementia

Free Alzheimer Society of BC webinars help local residents and caregivers living with dementia. (Alzheimer’s Society of B.C. photo)
Scene from the 2019 Climb for Alzheimer’s. (Submitted)

Trail invited to ‘Climb’

70,000-kilometre hiking challenge to support people living with dementia

Scene from the 2019 Climb for Alzheimer’s. (Submitted)
Join Canadians in a virtual walk for Alzheimer’s
Join Canadians in a virtual walk for Alzheimer’s
Visit the Alzheimer Society of B.C.’s website to sign up for an online session. (Submitted photo)

Dementia education and support goes virtual

Greater Trail residents invited to join Alzheimer’s B.C webinars

Visit the Alzheimer Society of B.C.’s website to sign up for an online session. (Submitted photo)
To sign up for a workshop call 1.778.774.2133 or email info.westkootenay@alzheimerbc.org. (Photo by bhuvanesh gupta on Unsplash)
To sign up for a workshop call 1.778.774.2133 or email info.westkootenay@alzheimerbc.org. (Photo by bhuvanesh gupta on Unsplash)